Probiotics are live microorganisms — most commonly bacteria from the Lactobacillus and Bifidobacterium genera, along with the yeast Saccharomyces boulardii — that are marketed to support digestive and immune health by adding to or supporting the bacteria already living in your gut. They’re sold as capsules, powders, drops, and added to foods like yogurt and kefir.
Why the strain matters more than the number on the label
Probiotic products are often marketed by their CFU (colony-forming unit) count, but strain, not CFU count alone, is what drives outcomes. Different strains of the same species can have completely different effects — a strain shown to help with one condition may do nothing for another. Formulations typically range from about 500 million to 1 trillion CFU per gram, with most studied doses providing at least around 5 billion CFU, but a higher CFU count on its own does not mean a product is more effective if it’s not the right strain for what you’re trying to address.
What does the evidence actually show for IBS?
This is one of the most common reasons people try probiotics, and the evidence is genuinely mixed. A large meta-analysis covering 82 trials and over 10,000 patients found that certain probiotics can reduce overall symptom burden and abdominal pain for some people with irritable bowel syndrome (IBS) — but the certainty of that evidence was rated low to very low for most strains under GRADE criteria, the standard system researchers use to grade evidence quality. A few specific strains have shown more consistent results in individual trials, including Lactobacillus plantarum 299V and Bifidobacterium longum 35624, but results vary considerably between studies, doses, and trial designs. In short: probiotics may help some people with IBS, but there’s no single “best” probiotic for it, and the evidence isn’t strong enough to call it a reliable fix for everyone.
Safety — and who should be cautious
Probiotics have a long history of apparently safe use in healthy people, with side effects usually limited to mild, self-limited symptoms like gas or bloating. However, the risk profile changes significantly for certain groups:
- Immunocompromised individuals — probiotic use has been linked to bacteremia (bacteria in the blood) and fungemia in people who are severely ill or immunocompromised.
- Hospitalized, post-surgical, or critically ill patients — conditions such as having a central venous catheter, acute pancreatitis, or organ transplant status often make probiotic use inadvisable.
- Patients undergoing chemotherapy or radiation, or with blood cancers, are considered particularly vulnerable to complications.
- Premature infants — the FDA has specifically warned healthcare providers about cases of severe and fatal infections in premature infants given probiotics.
If any of the above applies to you or someone you’re considering probiotics for, this is a decision to make with a doctor, not on your own.
This article is researched and fact-checked against peer-reviewed studies and government health databases (NIH National Center for Complementary and Integrative Health, NIH Office of Dietary Supplements, PubMed). It is not written or reviewed by a licensed medical professional, and it is not a substitute for personalized medical advice — talk to your doctor before starting probiotics, especially if you are immunocompromised, seriously ill, hospitalized, or considering them for an infant. See how we review.
Sources: NIH ODS Probiotics Fact Sheet for Health Professionals, NIH NCCIH: Probiotics Usefulness and Safety, NIH PMC: Efficacy of Probiotics for Irritable Bowel Syndrome
